申请人:Heemskerk Jill
公开号:US20120083495A1
公开(公告)日:2012-04-05
Compounds useful for the treatment of spinal muscular atrophy or other uses, as well as methods of using such compounds to increase SMN expression, increase EAAT2 expression, or increase the expression of a nucleic acid that encodes a translational stop codon introduced by mutation or frameshift.
有用于治疗脊髓性肌萎缩症或其他用途的化合物,以及使用这些化合物的方法来增加SMN表达,增加EAAT2表达或增加由突变或移码引入的翻译终止密码子编码的核酸表达的方法。